Skip to content

ORIENTATE

The use of a hyperthermia pelotte to acquire more representative vaginal temperature measurements during deep hyperthermia treatments for gynaecological cancer; a comparative cross-over study. - More representative vaginal temperature measurements with a hyperthermia pelotte during hyperthermia treatments for gynaecological cancer.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58319
Enrollment
27
Registered
2025-09-03
Start date
2026-03-03
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical, vaginal and endometrial cancers Gynaecological cancer

Interventions

The investigational product is a vaginal pelotte for DHT. The pelotte is a medical device. It is a round rod made of PTFE – polytetrafluoroethylene. The top 7 cm has a diameter of 20 mm and the bottom
1. Not commercially available and no CE certification.&nbsp
&nbsp
2. Fiberglass probes do not fit into the catheters of this pelotte.&nbsp

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women aged 18 or older diagnosed with gynaecological cancer Indication for EBRT with DHT Written informed consent 

Exclusion criteria

Exclusion criteria: Any condition potentially interfering with the understanding of the study requirements, informed consent procedure and completion of questionnairesIf the vaginal lumen is <4 cm. 

Design outcomes

Primary

MeasureTime frame
To assess whether the average vaginal temperature measured during DHT differs significantly between treatments performed with a pelotte and those with a standard vaginal probe.

Secondary

MeasureTime frame
Reproducibility of catheter placement, patient comfort, inter-fractional spread of the vaginal temperature and the average vaginal temperature at the tip (0 cm) and 2 cm from the tip with pelotte and with a standard vaginal probe.

Countries

Netherlands

Contacts

Public ContactA.F. Rink

Erasmus MC, Universitair Medisch Centrum Rotterdam

a.rink@erasmusmc.nl0107041314

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026